No problem with same strength but different doses [General Sta­tis­tics]

posted by Helmut Homepage – Vienna, Austria, 2013-07-18 01:17 (4314 d 18:13 ago) – Posting: # 11011
Views: 9,397

Hi Vasily!

❝ We said that it is not ethical since some subjects will get more drug than needed (risk of AEs), some subjects will get less drug (risk of tumor resistance).


Exactly. What else?

❝ We also provided a link to the FDA capecitabine GL.


Nice.

❝ Experts said that ok, the design is now acceptable and commented that we have to analyze the subset of the sample with the similar amount of drug taken.


Shit.

❝ I understand that this expert's position does not have strong scientific background, however obviously I cannot tell it to the expert.


You have to say it in a polite way. :-D The expert should not loose his/her face. Ask ElMaestro (our expert for clever wordings) for help. Since you used only one strength I don’t see a problem. The capecitabine guidance is a nice reference.

Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,669 registered users;
124 visitors (0 registered, 124 guests [including 9 identified bots]).
Forum time: 19:31 CEST (Europe/Vienna)

We should not speak so that it is possible
for the audience to understand us,
but so that it is impossible
for them to misunderstand us.    Quintilian

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5